Save information for later
Sign Up

Learn About Angiosarcoma of the Liver

View Main Condition: Angiosarcoma

What is the definition of Angiosarcoma of the Liver?
A malignant vascular neoplasm arising from the liver.
What are the alternative names for Angiosarcoma of the Liver?
  • Angiosarcoma of the liver
Who are the top Angiosarcoma of the Liver Local Doctors?
Elite in Angiosarcoma of the Liver
Elite in Angiosarcoma of the Liver
Kantonsspital St. Gallen, 
Sankt Gallen, SG, CH 

David Semela practices in Sankt Gallen, Switzerland. Mr. Semela is rated as an Elite expert by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Angiosarcoma of the Liver, Angiosarcoma, Hepatitis C, Hepatitis, and Liver Transplant.

Elite in Angiosarcoma of the Liver
Hepatology
Elite in Angiosarcoma of the Liver
Hepatology

University Of Louisville Physicians Inc

401 E Chestnut St, Suite 310, 
Louisville, KY 
Languages Spoken:
English

Matthew Cave is a Hepatologist in Louisville, Kentucky. Dr. Cave is rated as an Elite provider by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Angiosarcoma of the Liver, Alcoholic Cirrhosis, Hepatitis, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Angiosarcoma of the Liver
Hematology Oncology | Hematology | Oncology
Advanced in Angiosarcoma of the Liver
Hematology Oncology | Hematology | Oncology

University Hospitals Medical Group Inc

11100 Euclid Ave, 
Cleveland, OH 
Languages Spoken:
English, Hindi
Accepting New Patients
Offers Telehealth

Ankit Mangla is a Hematologist Oncology specialist and a Hematologist in Cleveland, Ohio. Dr. Mangla is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Melanoma, Adult Soft Tissue Sarcoma, Angiosarcoma of the Scalp, and Angiosarcoma. Dr. Mangla is currently accepting new patients.

What are the latest Angiosarcoma of the Liver Clinical Trials?
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Summary: The aim of this French multicenter retrospective study is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences. This retrospective cohort will be the backbone of future translational stud...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1, Open-Label, Dose-Escalation and Expansion Study of AGX101, a TM4SF1 Directed Antibody Drug Conjugate in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors

Summary: AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various dose levels in an all-comers advanced solid cancer patient population. AGX101will be administered intravenously. Dosing of AGX101 will be repeated once every 3, 6 or 9 weeks. Participants may continue study treatment until disease progressio...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center